Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase-Reference-Cited by-同舟云学术

Adiponutrin Functions as a Nutritionally Regulated Lysophosphatidic Acid Acyltransferase

Published:2012-05 Issue:5 Volume:15 Page:691-702
ISSN:1550-4131
Container-title:Cell Metabolism
language:en
Short-container-title:Cell Metabolism

Author:

Kumari Manju,Schoiswohl Gabriele,Chitraju Chandramohan,Paar Margret,Cornaciu Irina,Rangrez Ashraf Y.,Wongsiriroj Nuttaporn,Nagy Harald M.,Ivanova Pavlina T.,Scott Sarah A.,Knittelfelder Oskar,Rechberger Gerald N.,Birner-Gruenberger Ruth,Eder Sandra,Brown H. Alex,Haemmerle Guenter,Oberer Monika,Lass Achim,Kershaw Erin E.,Zimmermann Robert,Zechner Rudolf

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Physiology

Reference61 articles.

1. Nonalcoholic fatty liver disease;Adams;CMAJ,2005

2. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34;Agarwal;Nat. Genet.,2002

3. Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome;Basantani;J. Lipid Res.,2011

4. Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage;Baulande;J. Biol. Chem.,2001

5. Agpat6—a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium;Beigneux;J. Lipid Res.,2006

Cited by 260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PNPLA3 I148 M genetic variant in autoimmune hepatitis characterises advanced disease at diagnosis and reduced survival free of cirrhotic events and liver-related mortality;Journal of Translational Autoimmunity;2024-12

2. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy;Frontiers in Cell and Developmental Biology;2024-09-11

3. PPARγ regulates PNPLA3 in adipocytes in vitro and in vivo in healthy obese patients and mice with metabolic dysfunction-associated steatohepatitis;2024-08-09

4. A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease;International Journal of Molecular Sciences;2024-07-02

5. Genetic Variations and Nonalcoholic Fatty Liver Disease: Field Synopsis, Systematic Meta-Analysis, and Evidence* *;BIOMED ENVIRON SCI;2024